ABT-199, a BH3 mimetic that specifically targets Bcl-2, enhances the antitumor activity of chemotherapy, bortezomib and JQ1 in “double hit” lymphoma cells
Overview of attention for article published in Leukemia & Lymphoma, January 2015
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (91st percentile)
-
High Attention Score compared to outputs of the same age and source (98th percentile)
Readers on
- mendeley
- 37 Mendeley
- citeulike
- 1 CiteULike